Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 4;146(48):32919-32924.
doi: 10.1021/jacs.4c13687. Epub 2024 Nov 20.

Homologation of Carboxylic Acids Using a Radical-Polar Conjunctive Reagent

Affiliations

Homologation of Carboxylic Acids Using a Radical-Polar Conjunctive Reagent

Jonathan N Gruhin et al. J Am Chem Soc. .

Abstract

Homologations of organic molecules that add a carbon atom to the substrate are useful in drug discovery to access compounds with improved properties that otherwise present a synthetic challenge. Carboxylic acids are present in many bioactive molecules and are widely available building blocks for chemical synthesis, yet their direct homologation is unknown. This valuable transformation currently necessitates implementation of multistep processes that require the use of carboxylic acid derivatives rather than the native substrates, and commonly involves highly reactive and toxic reagents. Herein, we report the first one-step homologation directly from native carboxylic acids using a novel, bench-stable (1-phosphoryl)vinyl sulfonate reagent under mild conditions. This strategy was applied to a wide range of aliphatic carboxylic acid building blocks and biologically relevant complex molecules to access an array of ester, amide, and carboxylic acid homologues in a single step. The (1-phosphoryl)vinyl sulfonate reagent participates in complementary homologation protocols featuring either radical-chain transfer or organic photoredox catalysis and introduces a new synthon, the distonic acylium radical, for molecular diversification. We anticipate this strategy, which addresses a long-standing challenge in organic synthesis, will expedite drug discovery by enabling the rapid synthesis of diversified homologues.

PubMed Disclaimer

Conflict of interest statement

Notes

The authors declare no competing financial interest.

References

    1. Zabolotna Y; Volochnyuk DM; Ryabukhin SV; Horvath D; Gavrilenko KS; Marcou G; Moroz YS; Oksiuta O; Varnek A A Close-up Look at the Chemical Space of Commercially Available Building Blocks for Medicinal Chemistry. J. Chem. Inf. Model 2022, 62 (9), 2171–2185. - PubMed
    1. Mao F; Ni W; Xu X; Wang H; Wang J; Ji M; Li J Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs. Molecules 2016, 21 (1), 75. - PMC - PubMed
    1. Ertl P; Schuhmann T A Systematic Cheminformatics Analysis of Functional Groups Occurring in Natural Products. J. Nat. Prod 2019, 82 (5), 1258–1263. - PubMed
    1. Dunetz JR; Magano J; Weisenburger GA Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals. Org. Process Res. Dev 2016, 20 (2), 140–177.
    1. Laudadio G; Palkowitz MD; El-Hayek Ewing T; Baran PS Decarboxylative Cross-Coupling: A Radical Tool in Medicinal Chemistry. ACS Med. Chem. Lett 2022, 13 (9), 1413–1420. - PMC - PubMed

LinkOut - more resources